Commentary on provisions of Act Section 1: Access to innovative medical treatments
Section 1 provides that the purpose of the Act is to promote access to innovative medical treatments (including the off-label use of medicines or the use of unlicensed medicines) by making provision for a database of innovative medical treatments, and for access to information contained in that database.